Vancomycin and insulin used as models for oral delivery of peptides
- 31 January 1993
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 23 (1), 65-74
- https://doi.org/10.1016/0168-3659(93)90071-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond StrengthPharmaceutical Research, 1990
- The Effect of Sodium Tauro-24,25-Dihydrofusidate on the Nasal Absorption of Human Growth Hormone in Three Animal ModelsPharmaceutical Research, 1990
- Intranasal Glucagon as Remedy for Hypoglycemia: Studies in Healthy Subjects and Type I Diabetic PatientsDiabetes Care, 1989
- Vasopressin: A model for the study of effects of additives on the oral and rectal administration of peptide drugsJournal of Pharmaceutical Sciences, 1988
- Long-Term Use of Intranasal Insulin in Insulin-Dependent Diabetic PatientsDiabetes Care, 1987
- Intranasal Aerosolized InsulinNew England Journal of Medicine, 1985
- Mechanisms for the enhancement of the nasal absorption of insulin by surfactantsInternational Journal of Pharmaceutics, 1981
- Effect of surfactants on the nasal absorption of insulin in ratsInternational Journal of Pharmaceutics, 1981
- Bile salts promote the absorption of insulin from the rat colonLife Sciences, 1981
- Specific determination of blood glucose with o-toluidineClinica Chimica Acta; International Journal of Clinical Chemistry, 1962